Arthur E. Spiller M.D. Professor and Chair Deparment of Integrative Physiology and Pathobiology, Tufts University
Bio: Caroline Attardo Genco, Ph.D., is Professor and Chair of the Department of Integrative Physiology and Pathobiology at Tufts University School of Medicine. Dr. Genco has a distinguished history of excellence in biomedical research. She has fostered numerous collaborations across disciplines including immunology, infectious diseases, epidemiology, biomedical engineering, and public health. Her primary research focus is in the area of chronic inflammation and the role of the microbiome in systemic inflammatory disorders. Dr. Genco’s current studies on the role of oral, lung, and gut microbiota in vascular inflammation and atherosclerosis are centered on the relationship of the innate immune system to microbial induced chronic inflammation, atherosclerosis, and pancreatic cancer. Additional areas of focus include sexually transmitted infections, and respiratory infectious diseases.
Casey M. Theriot
Assistant Professor, North Carolina State University Raleigh NC USA
Bio: Casey Theriot, PhD, is an Assistant Professor in Infectious Diseases at NC State University College of Veterinary Medicine in Raleigh, NC. She received her undergraduate degree from the University of Georgia and received her PhD from NC State University in the Department of Microbiology. She then went on to complete a postdoctoral fellowship and independent research position with Dr. David Aronoff and Dr. Vincent Young at the University of Michigan Medical School, where she focused on defining the gastrointestinal tract microbiome and metabolome during resistance and susceptibility to Clostridium difficile colonization and infection in a mouse model. Dr. Theriot’s current research focuses on how gut microbial derived secondary bile acids inhibit the C. difficile life cycle using in vitro and in vivo models. She is also working on manipulating the gut microbiota to rationally alter the composition of the bile acid pool in the gut, which has the potential to improve preventative and therapeutic approaches against many human diseases.
Assistant Professor, University of Texas Houston
Bio: Charles Darkoh, Ph.D. is an Assistant Professor at the University of Texas Health Science Center, School of Public Health and Graduate School of Biomedical Sciences, Houston, Texas, USA. His laboratory focuses on pathogenesis and molecular basis of enteric infectious diseases with the goal to identify and understand the mechanisms of action of novel virulence factors, pathways, and unique microbial products that can be harnessed for diagnostics and therapeutics.
Assistant Professor Of Medicine , Brown University
Bio: Colleen R. Kelly, MD is a gastroenterologist at the Center for Women’s Gastrointestinal Medicine at the Lifespan Women’s Medicine Collaborative. She is an assistant professor of medicine in the Division of Gastroenterology at The Warren Alpert Medical School of Brown University. Her clinical and research interests include C. difficile infection and fecal microbiota transplantation.
Professor Experimental Bacteriology, Leiden University Medical Center
Bio: Ed Kuijper, MD, PhD, is a professor in Medical Microbiology, head of the National Reference Laboratory for Clostridium difficle infections and head of the National Donor Feces Bank. His research group studies pathogenesis and epidemiology of CDI, including the role of human microbiota.
Professor, Institute of Clinical Microbiology
Bio: Professor Elisabeth Nagy PhD, DSc, was the head of the Institute of Clinical Microbiology, University of Szeged, (Szeged, Hungary) till her retirement. She was also running the National Reference Laboratory for Anaerobes for Hungary. As the chair person (now secretary) of ESCMID Study Group on Anaerobic Infections (ESGAI) she was actively participating in numerous surveillances organised by this Study Group on resistance of different anaerobes. She was a member of the Executive Committee of ESCMID and also member of the Advisory Forum of the European Centre for Disease Prevention and Control (ECDC) for years. Her main interest is the role of anaerobes in different diseases, including the applicability of MALDI-TOF MS for their identification. Her research group has been dealing with the resistance mechanisms and their genetic background of Bacteroides strains. She is now the Editor-in-Chief of ANAEROBE.
Ellie J.C. Goldstein
Director, R.M. Alden Research Lab Santa Monica CA USA
Bio: Ellie JC Goldstein, MD is a Clinical Professor of Medicine at David Geffen School of Medicine at UCLA and Director of the R M Alden Research Laboratory. His lab studies the role of anaerobes in clinical infections including animal and human bite wounds, intra-abdominal infection as well as C difficile infections. They also perform AST using the agar dilution method. He is also a practicing ID consultant in Santa Monica and chairs several Infection Control and ASP committees.
Eric A. Johnson
Professor, University of Wisconsin Madison WI USA
Bio: Eric Johnson, Sc.D. is a Professor in the Department of Bacteriology at the University of Wisconsin - Madison. His research focuses on Clostridium botulinum and its potent neurotoxin.
Prof.Dr., PhD, RWTH University Hospital Aachen Germany
Bio: Georg Conrads, PhD, is a Professor and head of the Division of Oral Microbiology and Immunology and Department of Operative Dentistry, Periodontology and Preventive Dentistry. His lab studies oral and odontogenic infections. The favorite subjects to study (among many others) are Archaea, Fusobacteria, Prevotella and Porphyromonas but also Streptococci and their contribution to caries, periodontitis, peri-implantitis and endodontic but also systemic infections. He likes (besides music and dancing) molecular as well as conventional methods.
Assistant Professor, Texas A&M University
Bio: Joe Sorg, Ph.D. is an Assistant Professor at Texas A&M University in the Department of Biology. He and his lab study the mechanisms of Clostridium difficile spore germination and disease.
Joseph S. Solomkin
Professor of Surgery, University of Cincinnati College of Medicine
Bio: Joseph S. Solomkin, MD, FACS, FIDSA, practiced acute care and burn surgery at the University of Cincinnati Hospitals, and developed a major interest in clinical infections as seen in such surgical patients, and in the conduct of trials for investigational drugs. He was Director of the Division of Surgical Infections, within the Department of Surgery. This group also had an NIH-funded research activity and T32 training grant studying the immunologic consequences of trauma. Since becoming Emeritus in 2009, Dr. Solomkin has created and leads a non-profit, OASIS Global, involved in the reduction of surgical site infections in low and middle income countries.
Professor, McMaster University
Bio: Michael Surette, PhD, is currently Professor and Canada Research Chair Interdisciplinary Microbiome Research in the Department of Medicine and Department of Biochemistry and Biomedical Sciences at McMaster University (Hamilton, Ont, CANADA). He is also co-director of the McMaster Genomics Facility. Dr. Surette’s research addresses the human microbiome of the respiratory and gastrointestinal tracts in health and disease, and the development of the microbiome in early life and as we age.
Research Associate Scientist, Veterans Affairs Medical Center Boise ID
Bio: Michael Aldape, PhD, is an Associate Research Scientist with the Infectious Diseases Research Group at the Veterans Affairs Medical Center in Boise, ID. His laboratory studies the pathogenesis of clostridial (mainly Clostridium sordellii Clostridium difficile) infections, and the host-pathogen interactions associated with these deadly diseases.
Michael Mallozzi, Ph.D
Senior Research Associate, University of Arizona
Bio: Michael Mallozzi, Ph.D. is a senior research scientist at the School of Animal and Comparative Biomedical Sciences at the University of Arizona where he studies molecular mechanisms of Clostridium difficile pathogenesis. He also serves on the board of and as scientific advisor for the Gut Check Foundation which is dedicated to raising awareness of and funding research on Clostridium septicum infections. Please visit the Gut Check Foundation table for more info.
PhD Student, University of Oklahoma, Norman Oklahoma
Bio: Nisha Patel is a PhD student in Microbiology at the University of Oklahoma under the advisement of Dr. Paul A. Lawson (Director of the Lawson Microbial Systematics Laboratory and the Center for Microbial Identification and Taxonomy). Her research involves the culturing and characterizing of novel anaerobes from human gut samples in a collaboration with the Laboratories of Molecular Anthropology and Microbiome Research
Professor of Microbiology, University of Oklahoma
Bio: Paul A. Lawson is a professor at the Department of Microbiology and Plant Biology at the University of Oklahoma. He has expertise in microbial systematics spanning over 30yrs and has been responsible or associated with, the naming or reclassification of over 140 bacteria that includes 2 families, 40 genera and almost 100 species. Although he has worked with diverse ecosystems that includes clinical, veterinary and environmental sources; the focus of much of his work is with the gastrointestinal tract of both man and animals. His work includes a fundamental restructuring of the genus Clostridium and relatives, and numerous contributions to the phylum
Firmicutes. In addition to original publications (160+), he has contributed 17 chapters to the Bergey’s Manual of Systematic Bacteriology, 3 chapters to Biodiversity and Taxonomy: Lactic Acid Bacteria and “Carnobacteriaceae" for “The Prokaryotes”. Paul is currently the Editor-in-Chief for the BISMiS Bulletin, an Associate Editor for IJSEM and chair of the Microbiology Section of the Oklahoma Academy of Sciences. In 2011 Paul established the Center for Microbial Identification and Taxonomy (CMIT) which, in addition to molecular tools offers chemotaxonomic and genomic services as a resource to the scientific community.
Associate Professor, CTOC DDS
Bio: Purnima Kumar DDS, PhD is an associate professor of periodontology at The Ohio State University. Her research focuses on human microbial ecology and its implications for health and disease.
Raina N. Fichorova
Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School
Bio: Raina Fichorova, MD, PhD, MA (Hon), is a Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and the Director of the Division of Genital Tract Biology within the Ob/Gyn Department of Brigham and Women’s Hospital. Her basic science lab is accredited by the College of American Pathologists for clinical biomarker validation. Dr. Fichorova studies the immunology of the female reproductive tract with focus on vaginal microbiota, Trichomonas vaginalis, inflammation, and their impact on reproductive and newborns’ health. Her latest research unveils galectin functions in bacterial-protozoan-host interactions and the role of protozoan endosymbiont viruses in human disease.
PhD Candidate, Vanderbilt University
Bio: Ramya Chandrasekaran is a Ph.D. student in the laboratory of Dr. Borden Lacy at Vanderbilt University. Her current research focuses on understanding the molecular and cellular mechanisms of entry and trafficking of a toxin secreted by Clostridium difficile. Ramya has received funding for her work from the American Heart Association and the Vanderbilt Institute of Clinical and Translational Research (VICTR).
Lecturer in Metabonomics, University of Reading
Bio: Sandrine Claus is Associate Professor in Integrative Metabolism at the University of Reading. Her current research focuses on understanding the biological mechanisms underpinning the relationship between gut microbial ecology and host metabolism in health and disease.
Glenn S. Tillotson
SVP Medical Affairs, Cempra Pharmacueticals Chapel Hill NC USA
Bio: Glenn Tillotson PhD, FIDSA, FCCP is SVP Medical Affairs at Cempra Inc. His interests include developing drugs and therapies for Clostridium difficile and the implications of antibiotic resistance in a range of bacterial infections.
Bio: Dr. Therien is currently a Director in the Infectious Diseases Department at Merck, leading various drug discovery programs focused on multi-drug resistant bacterial infections. Of note, he leads the preclinical work on bezlotoxumab, an antitoxin antibody that recently successfully completed phase 3 clinical trials and is being developed for the prevention of recurrent C. difficile infections.
Carl Erik Nord
Karolinska Institute Stockholm
Bio: Carl Erik Nord is senior professor of Medicine at Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden. His main research areas are infections caused by Clostridium difficile and Bacteroides fragilis
Bio: Associate Professor Dena Lyras is an ARC Future Fellow located in the Department of Microbiology at Monash University, Australia, and she is Vice-President of the Australian Society for Microbiology (ASM). Her research team studies the role played by regulatory and virulence factors encoded by the clostridia and how these factors influence disease in the host.
University Of Minnesota-Duluth
Bio: My research focuses on microbe-microbe interactions anaerobic gut microorganisms in humans and hibernating 13 lined gut squirrels. Difficult to grow and thermodynamically challenged microbes are my specialty.
Bio: Joseph P. Zackular, PhD received his Bachelor’s and Master’s degrees at the University of Massachusetts, Amherst. While at the University of Massachusetts, he performed research in the laboratories of Dr. Pablo Pomposiello and Dr. Patrick Schloss. In February of 2014, he received his PhD from the University of Michigan, where he investigated the role of the gut microbiome in colorectal cancer in the laboratory of Dr. Patrick Schloss. In March of 2016, he received The Ward J. MacNeal Educational and Scientific Memorial Trust Distinguished Dissertation Award from the Department of Microbiology and Immunology at the University of Michigan. In April of 2014, he joined the laboratory of Dr. Eric Skaar at Vanderbilt University. He is currently studying the impact of dietary metals and metal availability on the gut microbiome and C. difficile infection. He has received several awards for his research and is currently supported by a Ruth L. Kirschstein National Research Service Award (F32) from the NIAID.
Bio: Leandro is currently a professor in the medical microbiology department at the Federal University of Rio de Janeiro, Brazil. Leandro Lobo is interested in understanding how bacterial virulence factors contribute to the emergence of opportunistic infections caused by strict anaerobic commensals.
Bio: Maribeth Nicholson, MD MPH is an Assistant Professor in the Division of Pediatric Gastroenterology, Hepatology, and Nutrition at Vanderbilt University Medical Center. Her clinical and research activities focus on diarrheal illness and the role of Clostridium difficile in children.
University of California Davis CA USA
Bio: Mauricio Navarro, DVM, MSc, is a PhD student in Integrative Pathobiology at the University of California, Davis. He previously worked as a Professor of Veterinary Physiology and Pathophysiology at the Universidad Austral de Chile. He is currently focused on the study of the mechanisms of clostridial diseases of veterinary relevance, the use of animals models to decipher the pathogenesis of Clostridium perfringens enterotoxin, and diagnostic veterinary pathology.
University Of Cincinnati
Bio: Rajat Madan, MD, PhD is an Assistant Professor in the Division of Infectious Diseases and Department of Medicine at the University of Cincinnati. His lab studies the role of obesity-associated molecule leptin in controlling host neutrophil responses to Clostridium difficile infections. The lab uses samples (and clinical data) from patients with C. difficile and different murine models of C. difficile colitis to understand the role of lepin in disease pathogenesis and resolution.